RespireRx Pharmaceuticals Inc (RSPI)

[LTListener]

Agree in a sense that the company really hasnt provided any input recently as to milestones/targets, expectations, etc. Couple that with the convertible debt that needs to be mitigated, then I suppose it explains the fledgling stock. The only thing mentioned in recent press is hoping to find financing to advance the SCI/ADHD program later this year.

That leaves the OSA program, which has some funding set up in Australia and presumably conducting some pre-clinicals on new formulations?
And the pain/epilepsy candidate in NIH tier 3 trials, presumably underway but no idea when to expect results?
And CEO hoping to open "pursestrings" now with very positive preclinical data in hand.

Feels like very significant irons in the fire that when/if pulled out will be white hot. Just no idea on timing. Hoping 10-K will shed some insight.

GLTA.